Doç. Dr. Hayriye Şahinli
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Colorectal Neoplasms 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Head and Neck Neoplasms 2 publications
- Nasopharyngeal Carcinoma 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- Department name at the sourceOnkolojisaglik.gov.trFrom source
- InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
- Area of workColorectal NeoplasmsExtracted from 3 publications · Model version —From source
- Publications53 publicationsORCID, OpenAlexFrom source
- ORCID0000-0002-1561-9346ORCIDFrom source
- Last synchronised7 November 2026 00:02https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#hayriye-sahinlisaglik.gov.tr
Scientific work
Publications on Colorectal Neoplasms
-
Oxidative-Stress Biomarkers and Pathologic Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Prospective Cohort Study
Cancers, 2026
DOI 10.3390/cancers18121939 PMID 42352473 Open-access full textSource: ORCID
-
Prognostic value of the lymphocyte‑albumin‑neutrophil ratio in de novo metastatic colorectal cancer: A continuous‑variable analysis
Oncology Letters, 2026
DOI 10.3892/ol.2026.15922 Open-access full textSource: OpenAlex
-
Association Between Treatment-Emergent Pancreatic Volume Loss and Survival Outcomes in Patients with Metastatic Colorectal Cancer Receiving Bevacizumab
Medicina, 2026
DOI 10.3390/medicina62081459 PMID 42654356 Open-access full textSource: OpenAlex
-
Temporal trends in venous thromboembolism–related mortality among gastric cancer deaths in the United States, 1999–2020.
Turkish Journal of Clinics and Laboratory, 2026
DOI 10.18663/tjcl.1893840 Open-access full textSource: OpenAlex
-
Quality of Life and Patient-Reported Outcomes During First-Line Chemotherapy in Older Patients with De Novo Metastatic Gastrointestinal Cancers: A Prospective Longitudinal Study
Healthcare, 2026
DOI 10.3390/healthcare14203458 PMID 42940505 Open-access full textSource: ORCID
-
Prognostic and Treatment-Context Associations of EASIX and IPI in Extensive-Stage Small-Cell Lung Cancer Patients Receiving First-Line Therapy
Cancers, 2026
DOI 10.3390/cancers18172888 PMID 42738408 Open-access full textSource: ORCID
-
Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching
Current Oncology, 2026
DOI 10.3390/curroncol33080467 PMID 42645372 Open-access full textSource: ORCID
-
C-Reactive Protein–Albumin–Lymphocyte Index and the Modified Glasgow Prognostic Score as Predictors of Early Mortality After Palliative Percutaneous Transhepatic Biliary Drainage in Malignant Biliary Obstruction
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15124608 PMID 42355776 Open-access full textSource: ORCID
-
Inflammatory and Nutritional Biomarkers Predict Response to Neoadjuvant Dual Anti-HER2 Therapy in HER2-Positive Breast Cancer: A Retrospective Cohort Study
Cancer Management and Research, 2026
DOI 10.2147/cmar.s598948 PMID 42016158 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15062353 PMID 41899277 Open-access full textSource: ORCID